'Public health service act' presentation slideshows

Advances in the Treatment of Addiction: Shifting the Treatment Paradigm Again

Advances in the Treatment of Addiction: Shifting the Treatment Paradigm Again. Thomas E. Freese, Ph.D. UCLA Integrated Substance Abuse Programs. Disproportionate Impact on Persons with MI/SUDs. 20.4% SMI and 18.2% other mental disorder are uninsured , compared to 11.4% w/o mental disorder

628 views • 62 slides

John Schumann, MD Assistant Professor of Medicine MacLean Center for Clinical Medical Ethics Human Rights Program Univer

757 views • 52 slides

The Regulation of Drug and Biological Products Introduction to the Principles and Practice of Clinical Research

100 years. The Regulation of Drug and Biological Products Introduction to the Principles and Practice of Clinical Research. 250 years. Kathryn C. Zoon, Ph.D Acting Director DIR/NIAID January 2006. WHERE IS THE FDA? DHHS. Food and Drug Administration 2006. Acting Commissioner:

720 views • 49 slides

Report from DSHS

660 views • 35 slides

Current Good Manufacturing Practice: Vaccines

Current Good Manufacturing Practice: Vaccines. Mary Malarkey Director, Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research FDA Science Board; April 15, 2005. Summary:Vaccine CGMP. Statutes and regulations Unique challenges with Vaccines

707 views • 33 slides

The New Non-Discrimination Testing Rules

The New Non-Discrimination Testing Rules. Continuing Education - Presented by Susan P. Luskin, FLMI, CLU, CEBS, RHU. New non-discrimination requirements for group health plans. Non-Grandfathered plans must comply starting the first plan year following September 23, 2010 .

324 views • 32 slides

Risk Assessment

499 views • 31 slides

Pharmacist Volunteer Opportunities

428 views • 31 slides

Key Issues Impacting The Future of Biosimilars

Key Issues Impacting The Future of Biosimilars. Foley & Lardner Life Sciences Transactions Conference San Diego September 30, 2009 Michael A. Swit, Esq. Vice President. Standard Disclaimers. Views expressed here are solely mine and do not reflect those of my firm or any of its clients.

491 views • 28 slides

1.71k views • 27 slides

Evaluating Vaccine Effectiveness Using Serologic Assays

Evaluating Vaccine Effectiveness Using Serologic Assays. Cara R. Fiore, Ph D Office of Vaccines Research and Review Center for Biologics Evaluation and Review U. S. Food and Drug Administration Vaccines Europe, Brussels December 2011. Objectives. Background:

614 views • 27 slides

The Federal 340B Drug Discount Program: A Primer

The Federal 340B Drug Discount Program: A Primer. Andrea G. Cohen Manatt, Phelps & Phillips, LLP Presentation to the National Medicaid Congress June 4, 2006. 340B Program Overview What is it Who is eligible Pricing/Discounts and Pharmacy Arrangements Revenue/Savings Opportunities

660 views • 26 slides

Federal Authority for Isolation and Quarantine

Federal Authority for Isolation and Quarantine. Mary Trippler, Assistant U.S. Attorney.

547 views • 25 slides

Newborn Screening- who is doing what and why and where is it going?????

Newborn Screening- who is doing what and why and where is it going?????. Sara Copeland, MD Department of Health and Human Services Health Resources and Services Administration Medical Officer, Genetics Services Branch. Public Health and Genetics. Timeline of Genetics in HRSA.

412 views • 25 slides

1726 Stephen Hales first measures blood pressure in a horse

1726 Stephen Hales first measures blood pressure in a horse. 1796 Edward Jenner develops the world's first vaccine, against smallpox. Critics express skepticism, calling it ungodly to inoculate people with material from cows. . 1885 Louis Pasteur develops a vaccine for rabies.

596 views • 23 slides

1726 Stephen Hales first measures blood pressure in a horse

1726 Stephen Hales first measures blood pressure in a horse. 1796 Edward Jenner develops the world's first vaccine, against smallpox. Critics express skepticism, calling it ungodly to inoculate people with material from cows. . 1885 Louis Pasteur develops a vaccine for rabies.

809 views • 23 slides

CBER's policies on assay regulation: Definitions of assay performance characteristics

CBER's policies on assay regulation: Definitions of assay performance characteristics. Andrew I. Dayton, M.D., Ph.D. CBER. Regulation of In-Vitro Diagnostics (IVD). Center for Devices and Radiological Health (CDRH) Center for Biologics Evaluation and Research. IVDs in CBER.

416 views • 18 slides

Investigating Age Discrimination Complaints

Investigating Age Discrimination Complaints. 16 th Annual National Equal Opportunity Conference US Department of Labor Washington, DC August 25, 2005. Age Discrimination Act of 1975. Built on the foundation of Title VI HEW issued general government wide regulations in 1979

335 views • 16 slides

UPDATE ON NHANES DNA DATA DISCUSSION

UPDATE ON NHANES DNA DATA DISCUSSION. Board of Scientific Counselors September 18, 2008 Jennifer Madans. OP96S002. Introduction. Background: DNA has been collected (1991-94, 1999-2004, 2007+) by the NHANES program and is stored for future testing

340 views • 14 slides

Small Health Care Provider Quality Improvement (Rural Quality) Grant Program

Small Health Care Provider Quality Improvement (Rural Quality) Grant Program. Elizabeth Rezai-zadeh, MPH U.S. Department of Health & Human Services Health Resources & Services Administration Office of Rural Health Policy November 6, 2008. Background.

452 views • 9 slides